Growing community of inventors

Guangzhou, China

Tianzhi Wu

Average Co-Inventor Count = 3.71

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Tianzhi WuNong Zhang (6 patents)Tianzhi WuYuguang Wang (4 patents)Tianzhi WuZusheng Xu (3 patents)Tianzhi WuMin He (2 patents)Tianzhi WuQingrui Sun (2 patents)Tianzhi WuNong Zhang (0 patent)Tianzhi WuYuguang Wang (0 patent)Tianzhi WuQingrui Sun (0 patent)Tianzhi WuTianzhi Wu (6 patents)Nong ZhangNong Zhang (13 patents)Yuguang WangYuguang Wang (12 patents)Zusheng XuZusheng Xu (18 patents)Min HeMin He (15 patents)Qingrui SunQingrui Sun (7 patents)Nong ZhangNong Zhang (0 patent)Yuguang WangYuguang Wang (0 patent)Qingrui SunQingrui Sun (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Guangzhou Maxinovel Pharmaceuticals Co., Ltd. (4 from 10 patents)

2. Shanghai Yingli Pharmaceutical Co., Ltd (2 from 11 patents)

3. Beijing Maxinovel Pharmaceuticals Co., Ltd. (0 patent)


6 patents:

1. 12473300 - Thienopyrimidine derivative and preparation method therefor

2. 11384048 - Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application

3. 11078192 - Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof

4. 11066413 - Aminopyrimidine five-membered heterocyclic compound, and intermediate, preparation method, pharmaceutical composition and application thereof

5. 10100015 - Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof

6. 10100016 - Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/9/2026
Loading…